Cure My Disease

Don't miss your cure!

 Log in / Sign up

A phone program for parents may help black teens with diabetes control blood sugar

NCT ID NCT06275412

Disease control Sponsor: Wayne State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests a mobile health program called The 3Ms 2.0 for primary caregivers of Black adolescents with type 1 diabetes. The program uses interactive online sessions, video clips, and text messages to encourage daily parental monitoring of diabetes care. Researchers will compare it to an educational control to see if it improves blood sugar control, reduces family conflict, and eases caregiver distress. The study involves 216 Black adolescents aged 10 to 14 and their caregivers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
The 3Ms 2.0, a culturally tailored mobile health intervention for caregivers, delivered via an internet platform with interactive sessions, video clips, and text messages.
What this could lead to
If effective, this program could offer a practical way to improve blood sugar control and reduce diabetes-related family conflict and caregiver distress in Black adolescents with type 1 diabetes.
What could go wrong
The trial is early and the outcome depends on caregiver engagement. The intervention may not produce lasting improvements, and results may not apply to all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 216 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 10 years, 0 months - 14 years, 11 months * Diagnosed with Type 1 diabetes * Diagnosed for at least 6 months * Black * Primary caregiver willing to participate * Residence within 30 miles of a recruitment site * Caregiver ownership of an Internet-enabled device (cell phone, laptop or desktop computer, tablet, etc) Exclusion Criteria: * Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality) * Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis) * Inability to speak or read English * Child is in out-of-home placement

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Family relations are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Family relations Type 1 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's National Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • LeBonheur Children's Hospital

    RECRUITING

    Memphis, Tennessee, 38103, United States

  • University of Tennessee Health Science Center-Memphis

    RECRUITING

    Memphis, Tennessee, 38163, United States

  • Wayne Pediatrics

    RECRUITING

    Detroit, Michigan, 48201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.